Mahdi Mahdi

Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial

Sanjay Ramakrishnan, Dan V. Nicolau, Beverly Langford et al. · The Lancet Respiratory Medicine · 2021 · 434 citations · Full text

Pharmacy, Clinical Sciences, Pharmacotherapy +13

Treating eosinophilic exacerbations of asthma and COPD with benralizumab (ABRA): a double-blind, double-dummy, active placebo-controlled randomised trial

Sanjay Ramakrishnan, Richard Russell, Hafiz Taha Mahmood et al. · The Lancet Respiratory Medicine · 2024 · 103 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +12

Clinical trials and progress with paclitaxel in ovarian cancer

Sanjeev Kumar, Mahdi Mahdi, Shah et al. · International Journal of Women s Health · 2010 · 100 citations · Full text

Medicine, Oncology, Pharmacology +17

Blood eosinophil-guided oral prednisolone for COPD exacerbations in primary care in the UK (STARR2): a non-inferiority, multicentre, double-blind, placebo-controlled, randomised controlled trial

Sanjay Ramakrishnan, Helen Jeffers, B Langford-Wiley et al. · The Lancet Respiratory Medicine · 2023 · 72 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +17

Livelihood Change and Livelihood Sustainability in the Uplands of Lembang Subwatershed, West Sumatra, Indonesia, in a Changing Natural Resource Management Context

Mahdi Mahdi, Ganesh P. Shivakoti, Dietrich Schmidt‐Vogt · Environmental Management · 2008 · 60 citations

Social Sciences, Environmental Management, Sustainable Resource Management +17